FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087968969> ?p ?o ?g. }

• W2087968969 endingPage "953" @default.
• W2087968969 startingPage "940" @default.
• W2087968969 abstract "Abstract Objective: Heterozygous mutations in the GBA1 gene elevate the risk of Parkinson disease and dementia with Lewy bodies; both disorders are characterized by misprocessing of α‐synuclein (SNCA). A loss in lysosomal acid–β‐glucosidase enzyme (GCase) activity due to biallelic GBA1 mutations underlies Gaucher disease. We explored mechanisms for the gene's association with increased synucleinopathy risk. Methods: We analyzed the effects of wild‐type (WT) and several GBA mutants on SNCA in cellular and in vivo models using biochemical and immunohistochemical protocols. Results: We observed that overexpression of all GBA mutants examined (N370S, L444P, D409H, D409V, E235A, and E340A) significantly raised human SNCA levels to 121 to 248% of vector control ( p < 0.029) in neural MES23.5 and PC12 cells, but without altering GCase activity. Overexpression of WT GBA in neural and HEK293‐SNCA cells increased GCase activity, as expected (ie, to 167% in MES‐SNCA, 128% in PC12‐SNCA, and 233% in HEK293‐SNCA; p < 0.002), but had mixed effects on SNCA. Nevertheless, in HEK293‐SNCA cells high GCase activity was associated with SNCA reduction by ≤32% ( p = 0.009). Inhibition of cellular GCase activity (to 8–20% of WT; p < 0.0017) did not detectably alter SNCA levels. Mutant GBA‐induced SNCA accumulation could be pharmacologically reversed in D409V‐expressing PC12‐SNCA cells by rapamycin, an autophagy‐inducer (≤40%; 10μM; p < 0.02). Isofagomine, a GBA chaperone, showed a related trend. In mice expressing two D409V gba knockin alleles without signs of Gaucher disease (residual GCase activity, ≥20%), we recorded an age‐dependent rise of endogenous Snca in hippocampal membranes (125% vs WT at 52 weeks; p = 0.019). In young Gaucher disease mice (V394L gba +/+//prosaposin[ ps ]‐null// ps ‐transgene), which demonstrate neurological dysfunction after age 10 weeks (GCase activity, ≤10%), we recorded no significant change in endogenous Snca levels at 12 weeks of age. However, enhanced neuronal ubiquitin signals and axonal spheroid formation were already present. The latter changes were similar to those seen in three week‐old cathepsin D‐deficient mice. Interpretation: Our results demonstrate that GBA mutants promote SNCA accumulation in a dose‐ and time‐dependent manner, thereby identifying a biochemical link between GBA1 mutation carrier status and increased synucleinopathy risk. In cell culture models, this gain of toxic function effect can be mitigated by rapamycin. Loss in GCase activity did not immediately raise SNCA concentrations, but first led to neuronal ubiquitinopathy and axonal spheroids, a phenotype shared with other lysosomal storage disorders. ANN NEUROL 2011;" @default.
• W2087968969 created "2016-06-24" @default.
• W2087968969 creator A5000268173 @default.
• W2087968969 creator A5012372114 @default.
• W2087968969 creator A5015630245 @default.
• W2087968969 creator A5030718432 @default.
• W2087968969 creator A5032467961 @default.
• W2087968969 creator A5042864917 @default.
• W2087968969 creator A5048203740 @default.
• W2087968969 creator A5048429146 @default.
• W2087968969 creator A5057590021 @default.
• W2087968969 creator A5057984337 @default.
• W2087968969 creator A5060510236 @default.
• W2087968969 creator A5073566314 @default.
• W2087968969 creator A5077759846 @default.
• W2087968969 creator A5080762163 @default.
• W2087968969 creator A5082977907 @default.
• W2087968969 creator A5090917194 @default.
• W2087968969 date "2011-04-06" @default.
• W2087968969 modified "2023-10-18" @default.
• W2087968969 title "Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing" @default.
• W2087968969 cites W1540698875 @default.
• W2087968969 cites W1548829534 @default.
• W2087968969 cites W1560487523 @default.
• W2087968969 cites W1566076711 @default.
• W2087968969 cites W1618454560 @default.
• W2087968969 cites W1975596553 @default.
• W2087968969 cites W1988044873 @default.
• W2087968969 cites W1989855060 @default.
• W2087968969 cites W1992253341 @default.
• W2087968969 cites W2001307857 @default.
• W2087968969 cites W2003260773 @default.
• W2087968969 cites W2004865303 @default.
• W2087968969 cites W2016489086 @default.
• W2087968969 cites W2017621114 @default.
• W2087968969 cites W2019895460 @default.
• W2087968969 cites W2022649483 @default.
• W2087968969 cites W2024891592 @default.
• W2087968969 cites W2025374131 @default.
• W2087968969 cites W2056276806 @default.
• W2087968969 cites W2057979657 @default.
• W2087968969 cites W2059359069 @default.
• W2087968969 cites W2072066672 @default.
• W2087968969 cites W2076425557 @default.
• W2087968969 cites W2097989918 @default.
• W2087968969 cites W2098490713 @default.
• W2087968969 cites W2108849025 @default.
• W2087968969 cites W2108865709 @default.
• W2087968969 cites W2111244888 @default.
• W2087968969 cites W2121981334 @default.
• W2087968969 cites W2135135613 @default.
• W2087968969 cites W2145036730 @default.
• W2087968969 cites W2154015832 @default.
• W2087968969 cites W2155738133 @default.
• W2087968969 cites W2157535220 @default.
• W2087968969 cites W2161615638 @default.
• W2087968969 cites W2163635263 @default.
• W2087968969 cites W2166374868 @default.
• W2087968969 cites W2166973588 @default.
• W2087968969 cites W2170281382 @default.
• W2087968969 cites W2431538147 @default.
• W2087968969 doi "https://doi.org/10.1002/ana.22400" @default.
• W2087968969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21472771" @default.
• W2087968969 hasPublicationYear "2011" @default.
• W2087968969 type Work @default.
• W2087968969 sameAs 2087968969 @default.
• W2087968969 citedByCount "278" @default.
• W2087968969 countsByYear W20879689692012 @default.
• W2087968969 countsByYear W20879689692013 @default.
• W2087968969 countsByYear W20879689692014 @default.
• W2087968969 countsByYear W20879689692015 @default.
• W2087968969 countsByYear W20879689692016 @default.
• W2087968969 countsByYear W20879689692017 @default.
• W2087968969 countsByYear W20879689692018 @default.
• W2087968969 countsByYear W20879689692019 @default.
• W2087968969 countsByYear W20879689692020 @default.
• W2087968969 countsByYear W20879689692021 @default.
• W2087968969 countsByYear W20879689692022 @default.
• W2087968969 countsByYear W20879689692023 @default.
• W2087968969 crossrefType "journal-article" @default.
• W2087968969 hasAuthorship W2087968969A5000268173 @default.
• W2087968969 hasAuthorship W2087968969A5012372114 @default.
• W2087968969 hasAuthorship W2087968969A5015630245 @default.
• W2087968969 hasAuthorship W2087968969A5030718432 @default.
• W2087968969 hasAuthorship W2087968969A5032467961 @default.
• W2087968969 hasAuthorship W2087968969A5042864917 @default.
• W2087968969 hasAuthorship W2087968969A5048203740 @default.
• W2087968969 hasAuthorship W2087968969A5048429146 @default.
• W2087968969 hasAuthorship W2087968969A5057590021 @default.
• W2087968969 hasAuthorship W2087968969A5057984337 @default.
• W2087968969 hasAuthorship W2087968969A5060510236 @default.
• W2087968969 hasAuthorship W2087968969A5073566314 @default.
• W2087968969 hasAuthorship W2087968969A5077759846 @default.
• W2087968969 hasAuthorship W2087968969A5080762163 @default.
• W2087968969 hasAuthorship W2087968969A5082977907 @default.
• W2087968969 hasAuthorship W2087968969A5090917194 @default.
• W2087968969 hasConcept C104317684 @default.
• W2087968969 hasConcept C126322002 @default.

• next